Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes

被引:110
作者
Elleri, Daniela [1 ,2 ]
Allen, Janet M. [1 ,2 ]
Kumareswaran, Kavita [2 ]
Leelarathna, Lalantha [2 ]
Nodale, Marianna [2 ]
Caldwell, Karen [2 ]
Cheng, Peiyao [3 ]
Kollman, Craig [3 ]
Haidar, Ahmad [2 ]
Murphy, Helen R. [2 ]
Wilinska, Malgorzata E. [1 ,2 ]
Acerini, Carlo L. [1 ]
Dunger, David B. [1 ,2 ]
Hovorka, Roman [1 ,2 ]
机构
[1] Univ Cambridge, Dept Paediat, Cambridge, England
[2] Inst Metab Sci, Metab Res Labs, Cambridge, England
[3] Jaeb Ctr Hlth Res, Tampa, FL USA
基金
英国医学研究理事会;
关键词
GLUCOSE MONITORING-SYSTEM; HEART-RATE; ARTIFICIAL PANCREAS; ACCELEROMETRY; HYPOGLYCEMIA; ROADMAP; ADULTS;
D O I
10.2337/dc12-0816
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-We evaluated the safety and efficacy of closed-loop basal insulin delivery during sleep and after regular meals and unannounced periods of exercise. RESEARCH DESIGN AND METHODS-Twelve adolescents with type 1 diabetes (five males; mean age 15.0 [SD 1.4] years; HbA(1c) 7.9 [0.7]%; BMI 21.4 [2.6] kg/m(2)) were studied at a clinical research facility on two occasions and received, in random order, either closed-loop basal insulin delivery or conventional pump therapy for 36 h. During closed-loop insulin delivery, pump basal rates were adjusted every 15 min according to a model predictive control algorithm informed by subcutaneous sensor glucose levels. During control visits, subjects' standard infusion rates were applied. Prandial insulin boluses were given before main meals (50-80 g carbohydrates) but not before snacks (15-30 g carbohydrates). Subjects undertook moderate-intensity exercise, not announced to the algorithm, on a stationary bicycle at a 140 bpm heart rate in the morning (40 min) and afternoon (20 min). Primary outcome was time when plasma glucose was in the target range (71-180 mg/dL). RESULTS-Closed-loop basal insulin delivery increased percentage time when glucose was in the target range (median 84% [interquartile range 78-88%] vs. 49% [26-79%], P = 0.02) and reduced mean plasma glucose levels (128 [19] vs. 165 [55] mg/dL, P = 0.02). Plasma glucose levels were in the target range 100% of the time on 17 of 24 nights during closed-loop insulin delivery. Hypoglycemia occurred on 10 occasions during control visits and 9 occasions during closed-loop delivery (5 episodes were exercise related, and 4 occurred within 2.5 h of prandial bolus). CONCLUSIONS-Day-and-night closed-loop basal insulin delivery can improve glucose control in adolescents. However, unannounced moderate-intensity exercise and excessive prandial boluses pose challenges to hypoglycemia-free closed-loop basal insulin delivery. Diabetes Care 36:838-844, 2013
引用
收藏
页码:838 / 844
页数:7
相关论文
共 32 条
[1]   New Features and Performance of a Next-Generation SEVEN-Day Continuous Glucose Monitoring System with Short Lag Time [J].
Bailey, Timothy ;
Zisser, Howard ;
Chang, Anna .
DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (12) :749-755
[2]  
Bequette B Wayne, 2005, Diabetes Technol Ther, V7, P28, DOI 10.1089/dia.2005.7.28
[3]   Reliability and validity of the combined heart rate and movement sensor Actiheart [J].
Brage, S ;
Brage, N ;
Franks, PW ;
Ekelund, U ;
Wareham, NJ .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2005, 59 (04) :561-570
[4]   Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure [J].
Brage, S ;
Brage, N ;
Franks, PW ;
Ekelund, U ;
Wong, MY ;
Andersen, LB ;
Froberg, K ;
Wareham, NJ .
JOURNAL OF APPLIED PHYSIOLOGY, 2004, 96 (01) :343-351
[5]   Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity [J].
Brage, Soren ;
Ekelund, Ulf ;
Brage, Niels ;
Hennings, Mark A. ;
Froberg, Karsten ;
Franks, Paul W. ;
Wareham, Nicholas J. .
JOURNAL OF APPLIED PHYSIOLOGY, 2007, 103 (02) :682-692
[6]   Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy [J].
Burdick, J ;
Chase, HP ;
Slover, RH ;
Knievel, K ;
Scrimgeour, L ;
Maniatis, AK ;
Klingensmith, GJ .
PEDIATRICS, 2004, 113 (03) :E221-E224
[7]  
Castle Jessica R, 2010, J Diabetes Sci Technol, V4, P1305
[8]   Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes [J].
Castle, Jessica R. ;
Engle, Julia M. ;
Youssef, Joseph E. L. ;
Massoud, Ryan G. ;
Yuen, Kevin C. J. ;
Kagan, Ryland ;
Ward, W. Kenneth .
DIABETES CARE, 2010, 33 (06) :1282-1287
[9]  
Clarke William L, 2005, Diabetes Technol Ther, V7, P776, DOI 10.1089/dia.2005.7.776
[10]   A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes [J].
El-Khatib, Firas H. ;
Russell, Steven J. ;
Nathan, David M. ;
Sutherlin, Robert G. ;
Damiano, Edward R. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (27) :27ra27